EAU 2017 - Prostate Cancer

Viewing 1-20 of 87 articles

EAU 2017: State-of-the-art lecture Levels of competence in mpMRI reporting

EAU 2017: State-of-the-art lecture : What do urologists need to know about mpMRI targeted biopsy?

EAU 2017: Discussant: Is PIRADS 2.0 standardized enough?

EAU 2017: Reading and interpreting mpMRI: PIRADS 2.0

EAU 2017: European Society of Urogenital Radiology (ESUR) lecture PI-RADS in clinical practice including differential diagnoses in prostate imaging

EAU 2017: Metastases and death after 15 year of follow-up in men with screen-detected low-risk prostate cancer treated with protocol based active surveillance, radical prostatectomy or radiotherapy (804)

EAU 2017: MRI as a follow up tool in active surveillance: results from an MRI-defined active surveillance cohort

EAU 2017: Multiparametric MRI represents an added value but not a substitute of follow-up biopsies in patients on active surveillance for low-risk prostate cancer

EAU 2017: Pathological findings at radical prostatectomy after initial active surveillance in low-risk prostate cancer patients. Did we miss the chance to cure?

EAU 2017: PTEN status in diagnostic biopsies predicts active surveillance rebiopsy Gleason upgrade, treatment change and adverse surgical histopathological findings

EAU 2017: Variation in the use of active surveillance for low-risk prostate cancer

EAU 2017: Metastases and death after 15 year of follow-up in men with screen-detected low-risk prostate cancer treated with protocol based active surveillance, radical prostatectomy or radiotherapy

EAU 2017: MRI as a follow up tool in active surveillance – results from an MRI-defined active surveillance cohort (387 men, median 5 year follow up)

EAU 2017: Risk-based selection for active surveillance: Results of the Movember Foundation’s Global Action Plan prostate cancer active surveillance (GAP3) initiative

EAU 2017: Variation in the use of active surveillance for low-risk prostate cancer

EAU 2017: State-of-the-art Lecture: EAU Guidelines on mCRPC – An Update

EAU 2017: Is There a Role for Local Treatment of Oligometastatic Disease? No

EAU 2017: Is There a Role for Local Treatment of Oligometastatic Disease? Yes

EAU 2017: State-of-the-art lecture Hereditary Prostate Cancer

EAU 2017: Active Surveillance for 3+4=7 Prostate Cancer - Pro

1
2
3
4
5

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.